Marker Therapeutics, Inc. (MRKR) stock
MRKRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.84+0.01 (+0.97%)
Close on Nov 17, 2026Market cap $13.95MP/E –Yield –
Marker Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Marker Therapeutics's pe ratio was 1.0× on Oct 31, 2016.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2016 | Oct 31, 2016 | 1.0× | – |
See a number that looks wrong?